Evaluation of innate lymphoid cells and their subsets in atopic dermatitis patients with and without dupilumab therapy

J Dermatolog Treat. 2024 Dec;35(1):2299721. doi: 10.1080/09546634.2023.2299721. Epub 2024 Jan 4.

Authors

Jarmila Čelakovská¹, Eva Čermáková², Petra Boudkova³, Jan Krejsek³

Affiliations

¹ Department of Dermatology and Venereology, Faculty Hospital and Medical Faculty of Charles University, Hradec Králové, Czech Republic.
² Department of Medical Biophysics, Medical Faculty of Charles University, Hradec Králové, Czech Republic.
³ Department of Clinical Immunology and Allergy, Faculty Hospital and Medical Faculty of Charles University, Hradec Králové, Czech Republic.

PMID: 38174384
DOI: 10.1080/09546634.2023.2299721

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Dermatitis, Atopic* / drug therapy
Humans
Immunity, Innate
Lymphocytes
Severity of Illness Index
Treatment Outcome

Substances

dupilumab
Antibodies, Monoclonal, Humanized